Evidence map›Paper›PMID 40304701›Full record

ArticleHuman molecular genetics2025

Driving Global Health equity and precision medicine through African genomic data.

Oyesola O Ojewunmi, Segun Fatumo

Abstract read
In one paragraph

Article in Human molecular genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Neuropsychiatry genetics in Africa.Nature communications · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Oyesola O OjewunmiPrecision Healthcare University Research Institute, Queen Mary University of London, Empire House, 67-75 New Road, London E1 1HH, United Kingdom.ORCID 0000-0003-2774-650X
Segun FatumoPrecision Healthcare University Research Institute, Queen Mary University of London, Empire House, 67-75 New Road, London E1 1HH, United Kingdom.ORCID 0000-0003-4525-3362

Funding

Wellcome TrustWellcome Trust 220740/Z/20/Z
6 · The paper itself

Abstract

Significant gaps persist despite the progress in raising awareness of genomic diversity and including individuals of African ancestry in genomic research. African populations remain underrepresented in genomic studies despite their deep evolutionary history, demographic diversity, and unique genetic architecture for gene discovery. This underrepresentation constrains the portability of findings from other populations to African settings due to the poor predictive performance of genetic scores. Consequently, it hinders global efforts in translational research, slows the progression of genomic medicine, and worsens health disparities-a missed opportunity for precision medicine globally. However, genuine prioritisation and expansion of genomic data collection from individuals of African ancestry can drive more equitable health solutions that benefit all populations. In this review, we highlight the opportunities presented by African genomic diversity, the urgent need for larger datasets and biobanks with diverse phenotypes from African populations, and recent developments in African genomic research.

Indexed as

African genomicsgenomic diversityglobal healthpolygenic risk scoreprecision medicine

Identifiers

PMID40304701
PMCPMC7619342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.